[go: up one dir, main page]

SI1732575T1 - Spojine, ki vsebujejo stroncij, za uporabo pri preprečevanju ali zdravljenju nekrotičnih kostnih stanj - Google Patents

Spojine, ki vsebujejo stroncij, za uporabo pri preprečevanju ali zdravljenju nekrotičnih kostnih stanj

Info

Publication number
SI1732575T1
SI1732575T1 SI200531257T SI200531257T SI1732575T1 SI 1732575 T1 SI1732575 T1 SI 1732575T1 SI 200531257 T SI200531257 T SI 200531257T SI 200531257 T SI200531257 T SI 200531257T SI 1732575 T1 SI1732575 T1 SI 1732575T1
Authority
SI
Slovenia
Prior art keywords
strontium
prevention
treatment
containing compounds
bone conditions
Prior art date
Application number
SI200531257T
Other languages
English (en)
Inventor
Christian Hansen
Henrik Nilsson
Stephan Christgau
Henry G Bone Iii
Original Assignee
Osteologix As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteologix As filed Critical Osteologix As
Priority claimed from PCT/DK2005/000140 external-priority patent/WO2005082385A1/en
Publication of SI1732575T1 publication Critical patent/SI1732575T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200531257T 2004-02-26 2005-02-28 Spojine, ki vsebujejo stroncij, za uporabo pri preprečevanju ali zdravljenju nekrotičnih kostnih stanj SI1732575T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54852904P 2004-02-26 2004-02-26
DKPA200400313 2004-02-26
PCT/DK2005/000140 WO2005082385A1 (en) 2004-02-26 2005-02-28 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
EP05706802A EP1732575B1 (en) 2004-02-26 2005-02-28 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions

Publications (1)

Publication Number Publication Date
SI1732575T1 true SI1732575T1 (sl) 2011-05-31

Family

ID=34956357

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531257T SI1732575T1 (sl) 2004-02-26 2005-02-28 Spojine, ki vsebujejo stroncij, za uporabo pri preprečevanju ali zdravljenju nekrotičnih kostnih stanj

Country Status (6)

Country Link
JP (1) JP4839302B2 (sl)
AT (1) ATE493137T1 (sl)
DE (1) DE602005025616D1 (sl)
DK (1) DK1732575T3 (sl)
PT (1) PT1732575E (sl)
SI (1) SI1732575T1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809286C (en) * 2009-09-11 2018-02-13 Straxcorp Pty Ltd Method and system for image analysis of selected tissue structures

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
WO2002080955A1 (en) * 2001-03-22 2002-10-17 Barnes-Jewish Hospital Stimulation of osteogenesis using rank ligand fusion proteins
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
US20040258730A1 (en) * 2001-11-12 2004-12-23 Yasuhiko Tabata Persistent filmy preparation for topical administration containing prostglandin derivative

Also Published As

Publication number Publication date
DE602005025616D1 (de) 2011-02-10
PT1732575E (pt) 2011-03-23
JP2007523916A (ja) 2007-08-23
ATE493137T1 (de) 2011-01-15
JP4839302B2 (ja) 2011-12-21
DK1732575T3 (da) 2011-03-28

Similar Documents

Publication Publication Date Title
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
PL1732575T3 (pl) Związki zawierające stron do stosowania w zapobieganiu lub leczeniu stanów nekrotycznych kości
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
IL183537A0 (en) Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
AP2007004245A0 (en) Compounds and methods for the treatment or prevention of flavivirus infections
GB2418025B (en) Device for the prevention or treatment of ulcers
IL187565A0 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
EP1809265A4 (en) METHOD FOR THE TREATMENT OF SYNNUCLEOPATHIES
IL187405A0 (en) Methods and compositions for the treatment of pain
EP1968505A4 (en) DEVICES AND METHOD FOR THE TREATMENT OF BONE FRACTURES
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
IL178827A0 (en) Use of reboxetine for the treatment of pain
PT1945243E (pt) Utilização da calcitonina para o tratamento da ar
HUP0500199A3 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
EP1933853A4 (en) TREATMENT OF TISSUE DISTRACTION AND COMPOSITION FOR APPLYING THEREOF
GB0415181D0 (en) Compounds for use in the treatment of infection
GB2427361B (en) Treatment device for the human body
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
SI1732575T1 (sl) Spojine, ki vsebujejo stroncij, za uporabo pri preprečevanju ali zdravljenju nekrotičnih kostnih stanj
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
EP1797430A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
GB2401044B (en) A composition for use in the treatment or prophylaxis of a skin condition in a subject
ZA200710476B (en) Methods and compositions for the treatment of pain